(Q38096957)

28 August 2017

Are current clinical trials in diabetes addressing important issues in diabetes care? (English)

1 reference

28 August 2017

W C Lakey

1

1 reference

28 August 2017

K Barnard

2

1 reference

28 August 2017

B C Batch

3

1 reference

28 August 2017

K Chiswell

4

1 reference

28 August 2017

A Tasneem

5

1 reference

28 August 2017

J B Green

6

1 reference

28 August 2017

8 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

56

1 reference

28 August 2017

6

1 reference

28 August 2017

1226-1235

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-013-2890-4

28 August 2017

0 references

cites work

Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

The American Diabetes Association diabetes research perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Effect of valsartan on the incidence of diabetes and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Prevalence of diabetic retinopathy in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Diabetic retinopathy in a multi-ethnic cohort in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Ethnic disparities in diabetic complications in an insured population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Does diabetes therapy influence the risk of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

The safety of incretin-based therapies--review of the scientific evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2890-4

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23564296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23564296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

International Diabetes Federation: a consensus on Type 2 diabetes prevention

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23564296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-013-2890-4

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference